161 related articles for article (PubMed ID: 34064877)
21. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT.
Chai L; Zhu N; Wang Q; Wang T; Chai W
Acad Radiol; 2021 May; 28(5):679-686. PubMed ID: 32591278
[TBL] [Abstract][Full Text] [Related]
23. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
24. Preoperative platelet-to-lymphocyte ratio improves the performance of the international consensus guidelines in predicting malignant pancreatic cystic neoplasms.
Goh BK; Teo JY; Allen JC; Tan DM; Chan CY; Lee SY; Tai DW; Thng CH; Cheow PC; Chow PK; Ooi LL; Chung AY
Pancreatology; 2016; 16(5):888-92. PubMed ID: 27421563
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
[TBL] [Abstract][Full Text] [Related]
26. Mural nodule of 10 mm or larger as predictor of malignancy for intraductal papillary mucinous neoplasm of the pancreas: Pathological and radiological evaluations.
Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
Pancreatology; 2016; 16(3):441-8. PubMed ID: 26804002
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
28. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
[TBL] [Abstract][Full Text] [Related]
29. Nomogram for the Prediction of High-Grade Dysplasia and Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on Variables of Noninvasive Examination.
Li B; Shi X; Gao S; Shen S; Bian Y; Cao K; Pan Y; Zhang G; Jiang H; Li G; Guo S; Jin G
Front Oncol; 2021; 11():609187. PubMed ID: 33767983
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
31. Significance of microcystic, elongated, and fragmented glandular-like features in intraductal papillary mucinous neoplasm of the pancreas.
Park JY; Lee JH; Song KB; Hwang DW; Kim KR; Kim SC; Hong SM
Hum Pathol; 2018 Aug; 78():18-27. PubMed ID: 29410139
[TBL] [Abstract][Full Text] [Related]
32. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
33. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
[TBL] [Abstract][Full Text] [Related]
34. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
[TBL] [Abstract][Full Text] [Related]
35. Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Pathology.
Grenacher L; Strauß A; Bergmann F; Birdsey M; Mayerle J
Viszeralmedizin; 2015 Feb; 31(1):31-7. PubMed ID: 26288613
[TBL] [Abstract][Full Text] [Related]
36. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
37. Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.
Moris M; Dawson DW; Jiang J; Lewis J; Nassar A; Takeuchi KK; Lay AR; Zhai Q; Donahue TR; Kelly KA; Crawford HC; Wallace M
Pancreas; 2016 Oct; 45(9):1353-8. PubMed ID: 27101571
[TBL] [Abstract][Full Text] [Related]
38. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
[TBL] [Abstract][Full Text] [Related]
39. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
[TBL] [Abstract][Full Text] [Related]
40. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
